Marie Thibault
Stock Analyst at BTIG
(3.63)
# 834
Out of 5,113 analysts
105
Total ratings
48.48%
Success rate
7.88%
Average return
Main Sectors:
Stocks Rated by Marie Thibault
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CBLL CeriBell | Reiterates: Buy | $30 | $20.55 | +45.99% | 2 | Jan 28, 2026 | |
| ABT Abbott Laboratories | Maintains: Buy | $145 → $140 | $106.05 | +32.01% | 15 | Jan 23, 2026 | |
| HAE Haemonetics | Reiterates: Buy | $88 | $66.06 | +33.21% | 4 | Jan 9, 2026 | |
| OM Outset Medical | Reiterates: Buy | $17 | $5.03 | +238.31% | 2 | Dec 16, 2025 | |
| EW Edwards Lifesciences | Maintains: Buy | $100 → $103 | $81.86 | +25.82% | 2 | Dec 5, 2025 | |
| MASI Masimo | Maintains: Buy | $198 → $200 | $137.67 | +45.27% | 7 | Dec 4, 2025 | |
| BSX Boston Scientific | Reiterates: Buy | $132 | $93.79 | +40.74% | 14 | Nov 21, 2025 | |
| PODD Insulet | Maintains: Buy | $370 → $380 | $258.20 | +47.17% | 6 | Nov 21, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Buy | $32 | $25.21 | +26.93% | 1 | Nov 18, 2025 | |
| ARAY Accuray | Maintains: Buy | $5 → $4 | $0.79 | +404.29% | 2 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $9.92 | +131.85% | 4 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $109 → $85 | $73.36 | +15.87% | 8 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $215 | $151.85 | +41.59% | 8 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $10.20 | +145.10% | 3 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.93 | - | 2 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $58 → $52 | $37.77 | +37.68% | 7 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $62 → $65 | $67.18 | -3.25% | 8 | Oct 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.27 | - | 2 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.32 | - | 3 | Oct 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.12 | - | 3 | Oct 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.82 | - | 1 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $6 | $361.12 | -98.34% | 1 | Apr 9, 2020 |
CeriBell
Jan 28, 2026
Reiterates: Buy
Price Target: $30
Current: $20.55
Upside: +45.99%
Abbott Laboratories
Jan 23, 2026
Maintains: Buy
Price Target: $145 → $140
Current: $106.05
Upside: +32.01%
Haemonetics
Jan 9, 2026
Reiterates: Buy
Price Target: $88
Current: $66.06
Upside: +33.21%
Outset Medical
Dec 16, 2025
Reiterates: Buy
Price Target: $17
Current: $5.03
Upside: +238.31%
Edwards Lifesciences
Dec 5, 2025
Maintains: Buy
Price Target: $100 → $103
Current: $81.86
Upside: +25.82%
Masimo
Dec 4, 2025
Maintains: Buy
Price Target: $198 → $200
Current: $137.67
Upside: +45.27%
Boston Scientific
Nov 21, 2025
Reiterates: Buy
Price Target: $132
Current: $93.79
Upside: +40.74%
Insulet
Nov 21, 2025
Maintains: Buy
Price Target: $370 → $380
Current: $258.20
Upside: +47.17%
Kestra Medical Technologies
Nov 18, 2025
Initiates: Buy
Price Target: $32
Current: $25.21
Upside: +26.93%
Accuray
Nov 6, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $0.79
Upside: +404.29%
Nov 4, 2025
Reiterates: Buy
Price Target: $23
Current: $9.92
Upside: +131.85%
Oct 31, 2025
Maintains: Buy
Price Target: $109 → $85
Current: $73.36
Upside: +15.87%
Oct 31, 2025
Maintains: Buy
Price Target: $195 → $215
Current: $151.85
Upside: +41.59%
Sep 5, 2025
Reiterates: Buy
Price Target: $25
Current: $10.20
Upside: +145.10%
Aug 20, 2025
Downgrades: Neutral
Price Target: n/a
Current: $3.93
Upside: -
Apr 30, 2025
Maintains: Buy
Price Target: $58 → $52
Current: $37.77
Upside: +37.68%
Oct 14, 2024
Maintains: Buy
Price Target: $62 → $65
Current: $67.18
Upside: -3.25%
Jun 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.27
Upside: -
Oct 6, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.32
Upside: -
Oct 13, 2021
Downgrades: Neutral
Price Target: n/a
Current: $2.12
Upside: -
Jan 21, 2021
Downgrades: Neutral
Price Target: n/a
Current: $6.82
Upside: -
Apr 9, 2020
Maintains: Buy
Price Target: $11 → $6
Current: $361.12
Upside: -98.34%